All - derm

All - derm

Each 100g cream contains:
Betamethasone Valerate 61mg (equivalent to betamethasone base 50mg)
Gentamicin Sulphate 166mg (equivalent to gentamicin base 100mg)
Tolnaftate 1g
Clioquinol 1g

All-derm cream combines the anti-inflammatory and antipruritic agent (betamethasone), the wide spectrum antibiotic (gentamicin), the fungicidal agent (tolnaftate), the antiseptic and antipruritic agent (clioquinol).
All-derm cream is indicated for the relief of the inflammatory manifestations of corticosteroid-responsive dermatosis when complicated by secondary infection caused by organisms sensitive to the components of this dermatologic preparation or when the possibility of such infection is suspected.
Such disorders include: Inguinal dermatosis and dermatophytosis, tinea pedis, tinea corporis, anal pruritus, balano-posthitis, intertrigo, angular-stomatitis, impetigo, follicular dermatitis, pustular acne, seborrheic dermatitis, eczema, contact dermatitis, photosensitivity dermatitis, eczematoid dermatitis, chronic dermatitis of the extremities, neurodermatitis, dyshidrosis and paronychia.


  • A thin film of cream should be applied to cover completely the affected area 2– 3 times daily or as prescribed by the physician.
  • Frequency of application and duration of therapy should be determined according to severity of the condition and patient response.
  • In cases of tinea pedis, longer therapy (2– 4 weeks) may be necessary.

Hypersensitivity to any of product components.

Side effects:
Local adverse reactions reported with the use of topical corticosteroids, especially under occlusive dressings, include: Burning, itching, irritation, dryness, folliculitis, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. Rash, irritation and hypersensitivity may occur with the topical usage of gentamicin, clioquinol and rarely with tolnaftate.

The product is not for ophthalmic use.
• Suitable precautions should be taken if extensive body surface areas are treated, occlusive technique is used, or when long term use is anticipated, because the topical effect may be converted to systemic effect including adrenal suppression, particularly in infants and children.
• Prolonged use of topical antibiotics may result in overgrowth of non-susceptible organisms, irritation, sensitization or super infection develops, if this occurs, treatment with the cream should be discontinued and appropriate therapy instituted.
• Systemic absorption of clioquinol may interfere with thyroid function tests. Slight staining of linens or clothing due to clioquinol may occur.

Use in pregnancy:
It should not be used in pregnancy in large amounts or for prolonged period of time.


Domina Pharmaceuticals
P.O. Box : 9622
Damascus - Syria


Phone: +963 (11) 33 192 32
Phone: +963 (11) 33 201 04
Mobile: +963 (932) 993 304 159
Mobile: +963 (932) 993 366 254